Mrowiec Fialek and Partners has advised the Argus Capital private equity fund on the sale of its minority stake in KCR S.A. to an unnamed buyer. KCR was advised by Weil, Gotshal & Manges.
Headquartered in Berlin, Germany, KCR employs more than 300 professionals in providing support to pharmaceutical, biotechnological, and medical industries in clinical trials. The company provides services to international pharmaceutical corporations and reports having "delivered solutions to most of the 20 top global pharmaceutical companies." It is present in 19 countries in both Europe and the USA, with clinical research being conducted mainly in Western, Central and Eastern Europe, as well as in the CIS countries.
The Mrowiec Fialek and Partners team included Partner Miroslaw Fialek, Senior Associate Pawel Cyganik, and Associates Malgorzata Banaszkiewicz-Miaskiewicz, Michal Nowodworski, and Martyna Marczewska.
From Weil, Gotshal & Manges, Partner Pawel Zdort and Associate Filip Lesniak worked on the transaction.